| Literature DB >> 29362255 |
Rowan W Johnson1, Sian A Williams2, Daniel F Gucciardi2, Natasha Bear3, Noula Gibson1,2,3.
Abstract
INTRODUCTION: Children with cerebral palsy (CP) and other neurodevelopmental disabilities often receive a home programme of exercises to assist in reaching their therapy goals. Adherence to exercise programmes is necessary to attain the level of practice required to achieve goals; however, adherence can be difficult to accomplish. In this paper, we describe the protocol for a randomised controlled trial to evaluate the effectiveness of delivering a home exercise programme to school-age children with disabilities using Physitrack, an online exercise prescription tool with a website or app interface. METHODS AND ANALYSIS: Participants aged 6-17 years, with CP or other neurodevelopmental disabilities, receiving community physiotherapy services in Western Australia, will be recruited. Participants will be stratified by age and functional mobility and randomised to either the intervention group, who will complete an 8-week home exercise programme using Physitrack, or the control group, who will complete an 8-week exercise programme without Physitrack. Researcher blinding to group allocation, and participant blinding to outcome, will be maintained. The primary outcome measures are adherence to the home exercise programme with weekly collection of home exercise logs; achievement of individualised goals by phone interview before and after intervention; and correctness of exercise performance by collection and analysis of videos of participants performing home exercises. Secondary outcome measures include enjoyment of physical activity, confidence to complete exercise programme, preferred method of delivery of programme and usability of Physitrack. A sample size of 58 participants will be necessary to see an effect on home programme adherence. Data will be analysed using the intention-to-treat principle. ETHICS AND DISSEMINATION: Ethical approval was obtained from Curtin University Human Research Ethics Committee in July 2016 (10391). Outcomes will be disseminated through publication in peer-reviewed journals and presentations at scientific conferences. TRIAL REGISTRATION NUMBER: ACTRN12616000743460; Pre-results. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: paediatric neurology; rehabilitation medicine
Mesh:
Year: 2018 PMID: 29362255 PMCID: PMC5786075 DOI: 10.1136/bmjopen-2017-018316
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Trial procedures flow diagram. COEP, Correctness of Exercise Performance; COPM, Canadian Occupational Performance Measure; NRS, Numeric Rating Scale; PACES, Physical Activity Enjoyment Scale; SUS, System Usability Scale.
Outcome assessments
| Outcome | Measure | Validity | Reliability |
| Self-rated adherence | Numerical Rating Scale (NRS) | Adherence measured with 11-point NRS correlates with adherence measured from exercise log books (r=0.62) | Not reported |
| Goal achievement | Canadian Occupational Performance Measure (COPM), adapted for children | Correlations of change in the adapted total COPM performance score with Goal Attainment Scaling (GAS) were all highly significant (P<0.05) and in moderate 0.35–0.49 Spearman’s correlation range | Alpha coefficient at each measurement occasion: |
| Exercise performance | Correctness of Exercise Performance (COEP) | ‘COEP is a simple tool although face validity has not been formally reported’. | Interobserver agreement reported: Kappa coefficient 0.88. |
| Enjoyment ofphysical activity | Physical Activity Enjoyment Scale in children | Significantly correlated with task goal orientation (r=0.65, P<0.01), athletic competence (r=0.23, P<0.01), physical appearance (r=0.20, P<0.01) and self –reported physical activity (r=0.16, P<0.01) | Acceptable internal reliability: alpha coefficient: 0.87. |
| Usability of technology | System Usability Scale | Not reported | Alpha coefficient: 0.85 |